Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in Type 2 Diabetes Mellitus

• Conditions: Type 2 Diabetes Mellitus; Non-Proliferative Diabetic Retinopathy; Diabetic Macular Edema

• Registration Number: NCT01107132
• Lead Sponsor: Soroka University Medical Center

Brief Summary

In Type 2 Diabetes mellitus patients we will:

1. quantify vasculopathy and blood-retinal barrier (BRB) leakage

2. measure blood-brain barrier (BBB) permeability and neuroanatomical changes

3. correlate BRB pathology with BBB breakdown, inflammatory markers and neuropsychiatric sequela

Detailed Description

Not available

Study Timeline

• Status Verified: 2010-04
• Study First Submitted: 2010-04-18
• Study First Submitted QC: 2010-04-19
• Last Update Submitted: 2010-04-19
• Study First Posted: 2010-04-20
• Last Update Posted: 2010-04-20
• Study Start: 2010-05

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Soroka University Medical Center; 🇮🇱 Beer-Sheva, Israel